Literature DB >> 16671456

Hydrocephalus in a rat model of intraventricular hemorrhage.

K R Lodhia1, P Shakui, R F Keep.   

Abstract

The aims of the current study were 1) to establish an adult rat model of intraventricular hemorrhage (IVH) and post-hemorrhagic ventricular dilatation, and 2) to examine the role of alterations in cerebrospinal fluid (CSF) drainage and parenchymal injury in that dilatation. Rats underwent infusion of 200 microl of autologous blood over 15 minutes. The rats were used to measure hematoma mass, ventricular dilatation, and cortical mantle volume (with T2 imaging), resistance to CSF absorption, and brain edema (as a marker of brain injury). IVH resulted in ventricular dilatation peaking at day 2 but persisting for at least 8 weeks. Although there was an increased resistance to CSF absorption at 3 days, it returned to normal at day 7. Long-term ventricular dilatation was not associated with an alteration in cortical mantle volume, although there was evidence of cortical damage (edema). It is possible that initial ventricular distension (due to the hematoma and the impaired CSF drainage) in combination with periventricular white matter damage results in structural changes that prevent total recoil once the hematoma has resolved and CSF drainage is normalized, leading to long-term hydrocephalus.

Entities:  

Mesh:

Year:  2006        PMID: 16671456     DOI: 10.1007/3-211-30714-1_45

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  20 in total

1.  Development of an acute obstructive hydrocephalus model in rats using N-butyl cyanoacrylate.

Authors:  Yong Sook Park; Seung Won Park; Jong Sik Suk; Taik Kyun Nam
Journal:  Childs Nerv Syst       Date:  2011-02-01       Impact factor: 1.475

2.  Prediction of Shunt Dependency After Intracerebral Hemorrhage and Intraventricular Hemorrhage.

Authors:  Lu-Ting Kuo; Hsueh-Yi Lu; Jui-Chang Tsai; Yong-Kwang Tu
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

3.  Inflammation of the choroid plexus and ependymal layer of the ventricle following intraventricular hemorrhage.

Authors:  Philippe F Simard; Cigdem Tosun; Ludmila Melnichenko; Svetlana Ivanova; Volodymyr Gerzanich; J Marc Simard
Journal:  Transl Stroke Res       Date:  2011-06       Impact factor: 6.829

Review 4.  Management of non-traumatic intraventricular hemorrhage.

Authors:  Thomas Gaberel; Christian Magheru; Evelyne Emery
Journal:  Neurosurg Rev       Date:  2012-06-26       Impact factor: 3.042

5.  Prx2 (Peroxiredoxin 2) as a Cause of Hydrocephalus After Intraventricular Hemorrhage.

Authors:  Xiaoxiao Tan; Jingyin Chen; Richard F Keep; Guohua Xi; Ya Hua
Journal:  Stroke       Date:  2020-04-13       Impact factor: 7.914

Review 6.  Brain endothelial cell junctions after cerebral hemorrhage: Changes, mechanisms and therapeutic targets.

Authors:  Richard F Keep; Anuska V Andjelkovic; Jianming Xiang; Svetlana M Stamatovic; David A Antonetti; Ya Hua; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-08       Impact factor: 6.200

7.  Role of iron in brain injury after intraventricular hemorrhage.

Authors:  Zhi Chen; Chao Gao; Ya Hua; Richard F Keep; Karin Muraszko; Guohua Xi
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

8.  Do current animal models of intracerebral hemorrhage mirror the human pathology?

Authors:  Opeolu Adeoye; Joseph F Clark; Pooja Khatri; Kenneth R Wagner; Mario Zuccarello; Gail J Pyne-Geithman
Journal:  Transl Stroke Res       Date:  2010-08-10       Impact factor: 6.829

Review 9.  Challenges for intraventricular hemorrhage research and emerging therapeutic targets.

Authors:  Thomas Garton; Ya Hua; Jianming Xiang; Guohua Xi; Richard F Keep
Journal:  Expert Opin Ther Targets       Date:  2017-10-30       Impact factor: 6.902

10.  Bilirubin oxidation products, oxidative stress, and intracerebral hemorrhage.

Authors:  J F Clark; M Loftspring; W L Wurster; S Beiler; C Beiler; K R Wagner; G J Pyne-Geithman
Journal:  Acta Neurochir Suppl       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.